(AIXA) AIXTRON SE - Overview
Stock: Deposition Equipment, MOCVD Systems, GaN Tools, SiC Reactors, Process Services
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.18% |
| Yield on Cost 5y | 0.96% |
| Yield CAGR 5y | 8.06% |
| Payout Consistency | 39.7% |
| Payout Ratio | 45.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 55.7% |
| Relative Tail Risk | -8.62% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.95 |
| Alpha | 42.73 |
| Character TTM | |
|---|---|
| Beta | 0.688 |
| Beta Downside | 0.891 |
| Drawdowns 3y | |
|---|---|
| Max DD | 75.94% |
| CAGR/Max DD | -0.08 |
Description: AIXA AIXTRON SE January 16, 2026
AIXTRON SE (XETRA:AIXA) designs, manufactures, and installs deposition equipment for semiconductor materials across Asia, Europe, and the United States, serving both high-volume production and R&D/pre-series lines.
Its portfolio spans tools such as the G10-SiC, G10-GaN, G10-AsP, and the AIX G5+ C reactor, covering compound-semiconductor and optoelectronic applications including lasers, LEDs, display tech, optical-wireless data links, and SiC/GaN power electronics.
Key financial metrics (FY 2023) show revenue of €1.03 bn, an EBIT margin of roughly 10 %, and an order backlog of €1.6 bn, indicating a solid pipeline despite the cyclical nature of capital-intensive equipment sales.
Sector drivers that materially affect AIXTRON’s outlook are the accelerating adoption of SiC and GaN devices in electric-vehicle powertrains, data-center inverters, and 5G infrastructure, as well as sustained R&D spend in the broader semiconductor ecosystem (global capex forecast to exceed $800 bn in 2024).
Assumption: the company can maintain its current market-share advantage in niche compound-semiconductor tools; uncertainty remains around macro-economic headwinds that could compress equipment spending cycles.
For a deeper quantitative assessment, you might explore ValueRay’s analyst tools to model AIXTRON’s valuation under different growth scenarios.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 90.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 17.84 > 1.0 |
| NWC/Revenue: 86.80% < 20% (prev 72.94%; Δ 13.86% < -1%) |
| CFO/TA 0.13 > 3% & CFO 126.6m > Net Income 90.7m |
| Net Debt (-80.1m) to EBITDA (130.2m): -0.62 < 3 |
| Current Ratio: 4.68 > 1.5 & < 3 |
| Outstanding Shares: last quarter (112.8m) vs 12m ago 0.18% < -2% |
| Gross Margin: 40.04% > 18% (prev 0.42%; Δ 3962 % > 0.5%) |
| Asset Turnover: 59.26% > 50% (prev 61.93%; Δ -2.67% > 0%) |
| Interest Coverage Ratio: 135.1 > 6 (EBITDA TTM 130.2m / Interest Expense TTM 845.0k) |
Altman Z'' 8.49
| A: 0.51 (Total Current Assets 658.3m - Total Current Liabilities 140.8m) / Total Assets 1.01b |
| B: 0.34 (Retained Earnings 347.2m / Total Assets 1.01b) |
| C: 0.11 (EBIT TTM 114.2m / Avg Total Assets 1.01b) |
| D: 3.10 (Book Value of Equity 459.1m / Total Liabilities 148.3m) |
| Altman-Z'' Score: 8.49 = AAA |
Beneish M -2.93
| DSRI: 1.18 (Receivables 136.2m/120.1m, Revenue 596.2m/620.6m) |
| GMI: 1.04 (GM 40.04% / 41.61%) |
| AQI: 0.96 (AQ_t 0.12 / AQ_t-1 0.12) |
| SGI: 0.96 (Revenue 596.2m / 620.6m) |
| TATA: -0.04 (NI 90.7m - CFO 126.6m) / TA 1.01b) |
| Beneish M-Score: -2.93 (Cap -4..+1) = A |
What is the price of AIXA shares?
Over the past week, the price has changed by +4.93%, over one month by -4.91%, over three months by +15.85% and over the past year by +53.44%.
Is AIXA a buy, sell or hold?
What are the forecasts/targets for the AIXA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 19.8 | -2.4% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 23.4 | 15.3% |
AIXA Fundamental Data Overview February 03, 2026
P/E Trailing = 24.5188
P/S = 3.7104
P/B = 2.5423
P/EG = 0.98
Revenue TTM = 596.2m EUR
EBIT TTM = 114.2m EUR
EBITDA TTM = 130.2m EUR
Long Term Debt = 3.10m EUR (from longTermDebtTotal, last fiscal year)
Short Term Debt = 1.92m EUR (from shortTermDebt, last fiscal year)
Debt = 5.02m EUR (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -80.1m EUR (from netDebt column, last quarter)
Enterprise Value = 2.06b EUR (2.21b + Debt 5.02m - CCE 153.4m)
Interest Coverage Ratio = 135.1 (Ebit TTM 114.2m / Interest Expense TTM 845.0k)
EV/FCF = 21.63x (Enterprise Value 2.06b / FCF TTM 95.4m)
FCF Yield = 4.62% (FCF TTM 95.4m / Enterprise Value 2.06b)
FCF Margin = 16.00% (FCF TTM 95.4m / Revenue TTM 596.2m)
Net Margin = 15.22% (Net Income TTM 90.7m / Revenue TTM 596.2m)
Gross Margin = 40.04% ((Revenue TTM 596.2m - Cost of Revenue TTM 357.5m) / Revenue TTM)
Gross Margin QoQ = 38.79% (prev 40.56%)
Tobins Q-Ratio = 2.04 (Enterprise Value 2.06b / Total Assets 1.01b)
Interest Expense / Debt = 3.60% (Interest Expense 181.0k / Debt 5.02m)
Taxrate = 16.07% (2.49m / 15.5m)
NOPAT = 95.8m (EBIT 114.2m * (1 - 16.07%))
Current Ratio = 4.68 (Total Current Assets 658.3m / Total Current Liabilities 140.8m)
Debt / Equity = 0.01 (Debt 5.02m / totalStockholderEquity, last quarter 861.8m)
Debt / EBITDA = -0.62 (Net Debt -80.1m / EBITDA 130.2m)
Debt / FCF = -0.84 (Net Debt -80.1m / FCF TTM 95.4m)
Total Stockholder Equity = 852.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 9.02% (Net Income 90.7m / Total Assets 1.01b)
RoE = 10.65% (Net Income TTM 90.7m / Total Stockholder Equity 852.3m)
RoCE = 13.35% (EBIT 114.2m / Capital Employed (Equity 852.3m + L.T.Debt 3.10m))
RoIC = 11.29% (NOPAT 95.8m / Invested Capital 849.1m)
WACC = 8.44% (E(2.21b)/V(2.22b) * Re(8.45%) + D(5.02m)/V(2.22b) * Rd(3.60%) * (1-Tc(0.16)))
Discount Rate = 8.45% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.11%
[DCF Debug] Terminal Value 68.25% ; FCFF base≈95.4m ; Y1≈62.6m ; Y5≈28.6m
Fair Price DCF = 5.31 (EV 518.9m - Net Debt -80.1m = Equity 599.0m / Shares 112.8m; r=8.44% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -18.43 | EPS CAGR: -31.72% | SUE: -2.03 | # QB: 0
Revenue Correlation: 21.77 | Revenue CAGR: -10.46% | SUE: -0.03 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.08 | Chg30d=-0.004 | Revisions Net=-2 | Analysts=3
EPS next Year (2026-12-31): EPS=0.63 | Chg30d=-0.022 | Revisions Net=-2 | Growth EPS=-3.8% | Growth Revenue=-2.4%